Korean Circ J.  2019 Jun;49(6):557-558. 10.4070/kcj.2018.0367.

Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing Multi-Modality Imaging

• Arsanjani
• Agasthi P
• Ahn DH
• Mookadam F
• Yang M

• KMID: 2454053
• DOI: http://doi.org/10.4070/kcj.2018.0367

Abstract

No abstract available.

MeSH Terms

Neuroendocrine Tumors*

Figure

• 

  Figure 1 Myocardial metastasis of neuroendocrine tumor. (A) A Gallium-68 DOTATATE PET/CT hybrid image demonstrating radiotracer uptake in the heart (arrows). (B) Transthoracic images demonstrating large echogenic mass (arrow) along the inferolateral wall of the LV. (C) Three-dimensional image confirming presence of large mass (arrow). (D) Contrast-enhanced echocardiographic image demonstrating minimal contrast uptake indicating minimal vascularity (arrow). (E) Turbo spin T2 sequence demonstrating multiple high T2 signal along the LV and RV wall correlating well with Gallium-68 DOTATATE PET images (arrows). (F) There is minimal late gadolinium enhancement on the cardiac MRI (arrow). CT = computed tomography; LV = left ventricle; MRI = magnetic resonance imaging; PET = positron emission tomography; RV = right ventricular.

Reference

1. Davar J, Connolly HM, Caplin ME, et al. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017; 69:1288–1304.

2. Bhattacharyya S, Toumpanakis C, Burke M, Taylor AM, Caplin ME, Davar J. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010; 3:103–111.